Bank of Montreal’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $426K | Buy |
9,865
+556
| +6% | +$24K | ﹤0.01% | 2096 |
|
|
2025
Q1 | $322K | Buy |
9,309
+133
| +1% | +$4.6K | ﹤0.01% | 2223 |
|
|
2024
Q4 | $252K | Buy |
9,176
+277
| +3% | +$7.6K | ﹤0.01% | 2352 |
|
|
2024
Q3 | $222K | Sell |
8,899
-626
| -7% | -$15.6K | ﹤0.01% | 2670 |
|
|
2024
Q2 | $260K | Buy |
9,525
+825
| +9% | +$22.5K | ﹤0.01% | 2563 |
|
|
2024
Q1 | $269K | Sell |
8,700
-18
| -0.2% | -$557 | ﹤0.01% | 2559 |
|
|
2023
Q4 | $366K | Sell |
8,718
-5,890
| -40% | -$247K | ﹤0.01% | 2331 |
|
|
2023
Q3 | $427K | Buy |
+14,608
| New | +$427K | ﹤0.01% | 2185 |
|
|
2023
Q2 | – | Sell |
-13,880
| Closed | -$246K | – | 3547 |
|
|
2023
Q1 | $246K | Buy |
+13,880
| New | +$246K | ﹤0.01% | 2634 |
|
|
2022
Q3 | – | Sell |
-10,001
| Closed | -$90 | – | 3534 |
|
|
2022
Q2 | $90 | Buy |
10,001
+628
| +7% | +$6 | ﹤0.01% | 3047 |
|
|
2022
Q1 | $97K | Sell |
9,373
-111,087
| -92% | -$1.15M | ﹤0.01% | 3165 |
|
|
2021
Q4 | $1.76M | Sell |
120,460
-6,205
| -5% | -$90.6K | ﹤0.01% | 1607 |
|
|
2021
Q3 | $6.24M | Buy |
126,665
+35,626
| +39% | +$1.76M | ﹤0.01% | 1398 |
|
|
2021
Q2 | $5.48M | Buy |
91,039
+7,693
| +9% | +$463K | ﹤0.01% | 1470 |
|
|
2021
Q1 | $4.84M | Buy |
83,346
+71,714
| +617% | +$4.17M | ﹤0.01% | 1208 |
|
|
2020
Q4 | $798K | Buy |
11,632
+7,863
| +209% | +$539K | ﹤0.01% | 2026 |
|
|
2020
Q3 | $148K | Sell |
3,769
-2,313
| -38% | -$90.8K | ﹤0.01% | 2497 |
|
|
2020
Q2 | $196K | Buy |
6,082
+5,068
| +500% | +$163K | ﹤0.01% | 2403 |
|
|
2020
Q1 | $25K | Sell |
1,014
-2,832
| -74% | -$69.8K | ﹤0.01% | 2855 |
|
|
2019
Q4 | $135K | Sell |
3,846
-486
| -11% | -$17.1K | ﹤0.01% | 2866 |
|
|
2019
Q3 | $93K | Sell |
4,332
-5,668
| -57% | -$122K | ﹤0.01% | 2868 |
|
|
2019
Q2 | $270K | Buy |
+10,000
| New | +$270K | ﹤0.01% | 2354 |
|